Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial cell membrane and biofilm extracellular matrix represent critical structural and protective components of pathogenic microorganisms. The cell membrane is a phospholipid bilayer that maintains cellular homeostasis, regulates nutrient transport, and preserves the electrochemical gradient necessary for ATP production (StatPearls, 2023). In many pathogenic contexts, microbes exist within biofilms, where they are encased in an extracellular matrix composed of extracellular polymeric substances (EPS) such as polysaccharides, proteins, and extracellular DNA (Nature Reviews Microbiology, 2010). This matrix acts as a physical and chemical barrier that shields the microbes from host immune responses and significantly limits the penetration of conventional antibiotics. Therapeutic strategies targeting these structures include membrane-disrupting agents like polymyxins and daptomycin, as well as matrix-degrading enzymes like dornase alfa (PubMed, 2019). Because these targets are essential for microbial survival and persistence, they are focal points for treating multi-drug resistant and chronic infections, although the potential for cross-reactivity with host cell membranes remains a significant safety challenge (NIH, 2022).
Drugs targeting these structures typically act through the disruption of membrane integrity, pore formation, or the enzymatic degradation of matrix components such as extracellular DNA (eDNA) and polysaccharides (StatPearls, 2023; Nature Reviews Microbiology, 2010). Membrane-active agents like polymyxins bind to lipopolysaccharides in Gram-negative bacteria, while polyenes like amphotericin B bind to ergosterol in fungal membranes to cause leakage of cellular contents (PubMed, 2019). Matrix-targeting agents like dornase alfa hydrolyze eDNA to reduce the viscosity of biofilm-rich secretions (FDA, 1993).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane and biofilm extracellular matrix.